28.29 USD
↘ 0.50 (1.74%)AT CLOSE (11:59 AM EDT)
Agios Pharmaceuticals, Inc.
AGIONASDAQ • USD
27.35
↘ 0.94 (3.34%)
POST MARKET (AS OF 05:14 PM EDT)
Post Market
AS OF 05:14 PM EDT
27.35
↘ 0.94 (3.34%)
Market: CLOSED
Open?$28.95
High?$29.39
Low?$28.13
Prev. Close?$28.79
Volume?561.3K
Avg. Volume?940.8K
VWAP?$28.52
Rel. Volume?0.60x
Bid / Ask
Bid?$24.63 × 100
Ask?$32.43 × 100
Spread?$7.80
Midpoint?$28.53
Valuation & Ratios
Market Cap?1.7B
Shares Out?59.5M
Float?57.6M
Float %?98.3%
P/E Ratio?N/A
P/B Ratio?1.52
EPS?-$7.11
Dividend?0.00%
Ex-Dividend?N/A
Agios Pharmaceuticals, Inc. (AGIO) is currently trading at $28.29. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. AGIO is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Address
88 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617-649-8600
CAMBRIDGE, MA 02139
Phone: 617-649-8600
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?100
Momentum?94
Short Sent.?49
Piotroski F-Score?3/9Weak
Altman Z-Score?12.04Safe
Confidence?53%Low
Short InterestHigh
Short % of Float?12.94%High
Short Interest?7.5M
Days to Cover?8.7
Free Float57.6M
Avg Daily Volume859.1K
Settlement Date2026-05-15
Financial Health
Current Ratio?14.19Strong
Quick Ratio?13.59Strong
Cash Ratio?1.93Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.52CHEAP▾
Peers100
S&P87
P/S?25.47HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.3CHEAP▾
S&P97
EV/Sales?23.75HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-38.1%WEAK▾
S&P3
ROA?-35.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-384727000
Enterprise Value?$1.6B
Fundamentals ratios updated end of day